XML 18 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Operating Activities    
Net income including the noncontrolling interests in subsidiaries $ 105,686 $ 105,377
Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities    
Amortization of deferred sales commissions 4,879 5,856
Depreciation and other amortization 5,179 4,859
Share-based compensation expense 12,234 12,927
(Gain) loss on disposal of assets (3,350) 1,394
Provision for deferred income taxes 7,121 11,911
Impairment of assets 0 1,637
Adoption of new accounting pronouncement 0 (2,653)
Net sales (purchases) of trading securities 13,579 (5,977)
Deferred sales commissions paid (2,846) (6,824)
Contingent deferred sales charges received 1,157 1,093
Other changes in assets and liabilities:    
Decrease (increase) in receivables, net 1,226 (5,532)
Increase in prepaid expenses and other assets (4,067) (4,756)
Decrease in accounts payable and accrued expenses (43,260) (26,019)
Increase (decrease) in other liabilities 1,390 (4,141)
Net cash provided by operating activities 98,928 89,152
Investing Activities    
Purchases of securities available for sale (1,401) (1,537)
Cash paid for business acquisitions (4,352) 0
Proceeds from redemptions of securities available for sale 17,349 151
Cash paid for property and equipment (3,461) (7,077)
Net cash provided (used) by investing activities 8,135 (8,463)
Financing Activities    
Dividends paid (50,937) (51,986)
Purchases of treasury stock (30,083) (35,197)
Distributions to noncontrolling interest in subsidiaries (5,860) (10,377)
Contributions from noncontrolling interest in subsidiaries 3,499 10,774
Cash paid for amended and restated credit agreement (483) 0
Proceeds from shareholders for share-based compensation 90 149
Cash paid for business acquisitions (210) (70)
Payments on debt (12,750) (12,750)
Net cash used by financing activities (96,734) (99,457)
Net increase (decrease) in cash and cash equivalents 10,329 (18,768)
Cash and cash equivalents, beginning of period 104,839 172,628
Cash and cash equivalents, end of period $ 115,168 $ 153,860